Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

NCT06808217 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06808217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06808217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
July 30, 2025
Completion date
April 1, 2027
Enrollment
550 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, farapulse, pulsed field ablation